Parental genomic imprinting in endocrinopathies

European Journal of Endocrinology

Volumn 147, Issue 5, 2002, Pages 561-569

  Polychronakos, Constantin ^a   Kukuvitis, Asterios ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ALBRIGHT SYNDROME; BECKWITH WIEDEMANN SYNDROME; BIRTH WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; ENDOCRINE DISEASE; GENETIC SUSCEPTIBILITY; GENOME IMPRINTING; HAPPY PUPPET SYNDROME; HUMAN; INFANT DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; INSULINOMA; MOLECULAR GENETICS; PARENT; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PSEUDOHYPOPARATHYROIDISM; REPRODUCTION; REVIEW; RNA TRANSCRIPTION; SEX DIFFERENCE; SILVER RUSSELL SYNDROME; TRANSIENT NEONATAL DIABETES MELLITUS;

EID: 0036856153     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1470561     Document Type: Review

References (65)

1. Surani MA, Barton SC & Norris ML. Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature 1984 308 548-550.
2. DeChiara TM, Efstratiadis A & Robertson EJ. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 1990 345 78-80.
3. Giannoukakis N, Deal C, Paquette J, Goodyer CG & Polychronakos C. Parental genomic imprinting of the human IGF2 gene. Nature Genetics 1993 4 98-101.
4. Li E, Beard C & Jaenisch R. Role for DNA methylation in genomic imprinting. Nature 1993 366 362-365.
5. Knoll JH, Nicholls RD, Magenis RE, Graham JM Jr, Lalande M & Latt SA. Angelman and Prader-Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion. American Journal of Medical Genetics 1989 32 285-290.
6. Carrel AL, Huber S, Allen DB & Voelkerding KV. Assessment of SNRPN expression as a molecular tool in the diagnosis of Prader-Willi syndrome. Molecular Diagnosis 1999 4 5-10.
7. Ohta T, Gray TA, Rogan PK, Buiting K, Gabriel JM, Saitoh S et al. Imprinting-mutation mechanisms in Prader-Willi syndrome. American Journal of Human Genetics 1999 64 397-413.
8. Buiting K, Dittrich B, Gross S, Lich C, Farber C, Buchholz T et al. Sporadic imprinting defects in Prader-Willi syndrome and Angelman syndrome: implications for imprint-switch models, genetic counseling, and prenatal diagnosis. American Journal of Human Genetics 1998 63 170-180.
9. Croteau S, Polychronakos C & Naumova AK. Imprinting defects in mouse embryos: stochastic errors or polymorphic phenotype? Genesis 2001 31 11-16.
10. Cassidy SB, Beaudet AL & Knoll JHM. Diagnostic testing for Prader-Willi and Angelman syndromes: report of the ASHG/ACMG Test and Technology Transfer Committee. American Journal of Human Genetics 1996 58 1085-1088.
11. Moncla A, Malzac P, Voelckel MA, Auquier P, Girardot L, Mattei MG et al. Phenotype-genotype correlation in 20 deletion and 20 non-deletion Angelman syndrome patients. European Journal of Human Genetics 1999 7 131-139.
12. Rougeulle C & Lalande M. Angelman syndrome: how many genes to remain silent? Neurogenetics 1998 1 229-237.
13. Mann MR & Bartolomei MS. Towards a molecular understanding of Prader-Willi and Angelman syndromes. Human Molecular Genetics 1999 8 1867-1873.
14. Preece MA, Price SM, Davies V, Clough L, Stanier P, Trembath RC et al. Maternal uniparental disomy 7 in Silver-Russell syndrome. Journal of Medical Genetics 1997 34 6-9.
15. Kotzot D, Schmitt S, Bernasconi F, Robinson WP, Lurie IW, Ilyina H et al. Uniparental disomy 7 in Silver-Russell syndrome and primordial growth retardation. Human Molecular Genetics 1995 4 583-587.
16. Joyce CA, Sharp A, Walker JM, Bullman H & Temple IK. Duplication of 7p12.1-p13, including GRB10 and IGFBP1, in a mother and daughter with features of Silver-Russell syndrome. Human Genetics 1999 105 273-280.
17. Monk D, Wakeling EL, Proud V, Hitchins M, Abu-Amero SN, Stanier P et al. Duplication of 7p11.2-p13, including GRB10, in Silver-Russell syndrome. American Journal Human Genetics 2000 66 36-46.
18. Hannula K, Lipsanen-Nyman M, Kontiokari T & Kere J. A narrow segment of maternal uniparental disomy of chromosome 7q31-qter in Silver-Russell syndrome delimits a candidate gene region. American Journal of Human Genetics 2001 68 247-253.
19. Blagitko N, Mergenthaler S, Schulz U, Wollmann HA, Craigen W. Eggermann T et al. Human GRB10 is imprinted and expressed from the paternal and maternal allele in a highly tissue- and isoform-specific fashion. Human Molecular Genetics 2000 9 1587-1595.
20. McCann JA, Zheng H, Islam A, Goodyer CG & Polychronakos C. Evidence against GRB10 as the gene responsible for Silver-Russell syndrome. Biochemical and Biophysical Research Communications 2001 286 943-948.
21. Hitchins MP, Monk D, Bell GM, Ali Z, Preece MA, Stanier P et al. Maternal repression of the human GRB10 gene in the developing central nervous system; evaluation of the role for GRB10 in Silver-Russell syndrome. European Journal of Human Genetics 2001 9 82-90.
22. Koufos A, Grundy P, Morgan K, Aleck KA, Hadro T, Lampkin BC et al. Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. American Journal of Human Genetics 1989 44 711-719.
23. Lee MP, DeBaun MR, Mitsuya K, Galonek HL, Brandenburg S, Oshimura M et al. Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting. PNAS 1999 96 5203-5208.
24. Frevel MA, Sowerby SJ, Petersen GB & Reeve AE. Methylation sequencing analysis refines the region of H19 epimutation in Wilms tumor. Journal of Biological Chemistry 1999 274 29331-29340.
25. Maher ER & Reik W, Beckwith-Wiedemann syndrome: imprinting in clusters revisited. Journal of Clinical Investigations 2000 105 247-252.
26. Webber AL, Ingram RS, Levorse JM & Tilghman SM. Location of enhancers is essential for the imprinting of H19 and Igf2 genes. Nature 1998 391 711-715.
27. Bell AC & Felsenfeld G. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 2000 405 482-485.
28. Zhang P, Liegeois NJ, Wong C, Finegold M, Hou H, Thompson JC et al. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 1997 387 151-158.
29. Orlow I, Iavarone A, Crider-Miller SJ, Bonilla F, Latres E, Lee MH et al. Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms' tumors. Cancer Research 1996 56 1219-1221.
30. von Muhlendahl KE & Herkenhoff H. Long-term course of neonatal diabetes. New England Journal of Medicine 1995 333 704-708.
31. Temple IK, Gardner RJ, Mackay DJ, Barber JC, Robinson DO & Shield JP. Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes. Diabetes 2000 49 1359-1366.
32. Gardner RJ, Mackay DJ, Mungall AJ, Polychronakos C, Siebert R, Shield JP et al. An imprinted locus associated with transient neonatal diabetes mellitus. Human Molecular Genetics 2000 9 589-596.
33. Varrault A, Bilanges B, Mackay DJ, Basyuk E, Ahr B, Fernandez C et al. Characterization of the methylation-sensitive promoter of the imprinted ZAC gene supports its role in transient neonatal diabetes mellitus. Journal of Biological Chemistry 2001 276 18653-18656.
34. Aguilar-Bryan L & Bryan J. Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocrine Reviews 1999 20 101-135.
35. Glaser B, Chiu KC, Anker R, Nestorowicz A, Landau H, Ben-Bassat H et al. Familial hyperinsulinism maps to chromosome 11p14-15.1, 30 cM centromeric to the insulin gene. Nature Genetics 1994 7 185-188.
36. Glaser B, Ryan F, Donath M, Landau H, Stanley CA, Baker L et al. Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylurea-receptor gene. Diabetes 1999 48 1652-1657.
37. de Lonlay P, Fournet JC, Rahier J, Gross-Morand MS, Poggi-Travert F, Foussier V et al. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. Journal of Clinical Investigation 1997 100 802-807.
38. Albright F. Psuedohypo-parathyroidism: an example of 'Seabright-Bantam syndrome'. Endocrinology 1942 30 922-932.
39. Fukumoto S, Suzawa M, Takeuchi Y, Kodama Y, Nakayama K, Ogata E et al. Absence of mutations in parathyroid hormone (PTH)/PTH-related protein receptor complementary deoxyribonucleic acid in patients with pseudohypoparathyroidism type Ib. Journal of Clinical Endocrinology and Metabolism 1996 81 2554-2558.
40. Juppner H, Schipani E, Bastepe M, Cole DE, Lawson ML, Mannstadt M et al. The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3. PNAS 1998 95 11798-11803.
41. Davies SJ & Hughes HE. Imprinting in Albright's hereditary osteodystrophy. Journal of Medical Genetics 1993 30 101-103.
42. Sullivan KA, Liao YC, Alborzi A, Beiderman B, Chang PH, Masters SB et al. Inhibitory and stimulatory G proteins of adenylate cyclase: cDNA and amino acid sequences of the alpha chains. PNAS 1986 83 6687-6691.
43. Yu S, Yu D, Lee E, Eckhaus M, Lee R, Corria Z et al. Variable and tissue-specific hormone resistance in heterotrimeric Gs protein alpha-subunit (Gsalpha) knockout mice is due to tissue-specific imprinting of the Gsalpha gene. PNAS 1998 95 8715-8720.
44. Campbell R, Gosden CM & Bonthron DT. Parental origin of transcription from the human GNAS1 gene. Journal of Medical Genetics 1994 31 607-614.
45. Zheng H, Radeva G, McCann JA, Hendy GN & Goodyer CG. Galphas transcripts are biallelically expressed in the human kidney cortex: implications for pseudohypoparathyroidism type 1b. Journal of Clinical Endocrinology and Metabolism 2001 86 4627-4629.
46. Schipani E, Weinstein LS, Bergwitz C, Iida-Klein A, Kong XF, Stuhrmann M et al. Pseudohypoparathyroidism type Ib is not caused by mutations in the coding exons of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene. Journal of Clinical Endocrinology and Metabolism 1995 80 1611-1621.
47. Liu J, Litman D, Rosenberg MJ, Yu S, Biesecker LG & Weinstein LS. A GNAS1 imprinting defect in pseudohypoparathyroidism type IB. Journal of Clinical Investigations 2000 106 1167-1174.
48. Bastepe M, Lane AH & Juppner H. Paternal uniparental isodisomy of chromosome 20q - and the resulting changes in GNAS1 methylation - as a plausible cause of pseudohypoparathyroidism. American Journal of Human Genetics 2001 68 1283-1289.
49. Warram JH, Krolewski AS, Gottlieb MS & Kahn CR. Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. New England Journal of Medicine 1984 311 149-152.
50. Paterson AD, Naimark DM & Petronis A. The analysis of parental origin of alleles may detect susceptibility loci for complex disorders. Human Heredity 1999 49 197-204.
51. Julier C, Hyer RN, Davies J, Merlin F, Soularue P, Briant L et al. Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility. Nature 1991 354 155-159.
52. Hitchins MP, Stanier P, Preece MA & Moore GE. Silver-Russell syndrome: a dissection of the genetic aetiology and candidate chromosomal regions. Journal of Medical Genetics 2001 38 810-819.
53. Vafiadis P, Bennett ST, Todd JA, Nadeau J, Grabs R, Goodyer CG et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nature Genetics 1997 15 289-292.
54. Vafiadis P, Grabs R, Goodyer CG, Colle E & Polychronakos C. A functional analysis of the role of IGF2 in IDDM2-encoded susceptibility to type 1 diabetes. Diabetes 1998 47 831-836.
55. Vafiadis P, Bennett ST, Todd JA, Grabs R & Polychronakos C. Divergence between genetic determinants of IGF2 transcription levels in leukocytes and of IDDM2-encoded susceptibility to type 1 diabetes. Journal of Clinical Endocrinology and Metabolism 1998 83 2933-2939.
56. Vafiadis P, Ounissi-Benkalha H, Palumbo M, Grabs R, Rousseau M, Goodyer CG et al. Class III alleles of the variable number of tandem repeat insulin polymorphism associated with silencing of thymic insulin predispose to type 1 diabetes. Journal of Clinical Endocrinology and Metabolism 2001 86 3705-3710.
57. Vafiadis P, Bennett ST, Colle E, Grabs R, Goodyer CG & Polychronakos C. Imprinted and genotype-specific expression of genes at the IDDM2 locus in pancreas and leucocytes. Journal of Autoimmunity 1996 9 397-403.
58. Moore GE, Abu-Amero SN, Bell G, Wakeling EL, Kingsnorth A, Stanier P et al. Evidence that insulin is imprinted in the human yolk sac. Diabetes 2001 50 199-203.
59. Chentoufi AA & Polychronakos C. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes 2002 51 1383-1390.
60. Manning M, Lissens W, Liebaers I, Van Steirteghem A & Weidner W. Imprinting analysis in spermatozoa prepared for intracytoplasmic sperm injection (ICSI). International Journal of Andrology 2001 24 87-94.
61. Young LE, Fernandes K, McEvoy TG, Butterwith SC, Gutierrez CG, Carolan C et al. Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture. Nature Genetics 2001 27 153-154.
62. Inoue K, Kohda T, Lee J, Ogonuki N, Mochida K et al. Faithful expression of imprinted genes in cloned mice. Science 2002 295 297.
63. Barlow DP, Stoger R, Herrmann BG, Saito K & Schweifer N. The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature 1991 349 84-87.
64. Haig D & Graham C. Genomic imprinting and the strange case of the insulin-like growth factor II receptor. Cell 1991 64 1045-1046.
65. Kukuvitis A, Georgiou I, Syrrou M, Andonikou S, Dickerman Z, Islam A et al. Lack of association of birth size with polymorphisms at GRB10 and IGF2R, two imprinted genes involved in fetal growth. Pediatric Research 2001 49 P3-P346.